Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID), 92820 [2016-30523]

Download as PDF 92820 Federal Register / Vol. 81, No. 244 / Tuesday, December 20, 2016 / Notices Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–30521 Filed 12–19–16; 8:45 am] BILLING CODE 4163–19–P The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention [FR Doc. 2016–30523 Filed 12–19–16; 8:45 am] BILLING CODE 4163–18–P mstockstill on DSK3G9T082PROD with NOTICES Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Time and Date: 11:00 a.m.–1:00 p.m., EST, January 23, 2017. Place: Teleconference. Status: The meeting is open to the public; the toll free dial in number is 1– 877–951–7311 with a pass code of 4530516. Purpose: The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: Strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers. Matters for Discussion: Topics to be discussed during the teleconference include (1) discussion and vote on the Food Safety Modernization Act Surveillance Working Group Annual Report to the Secretary of Health and Human Services and (2) a report back from a recent external review of CDC’s advanced molecular detection activities. The agenda and any supplemental material will be available at www.cdc.gov/oid/BSC/ meetingschedule.html after January 16. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Robin Moseley, M.A.T., Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639– 4461. VerDate Sep<11>2014 19:36 Dec 19, 2016 Jkt 241001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention announces the following committee meeting: Time and Date: 11:00 a.m.–2:00 p.m., EST, January 25, 2017. Place: Audio Conference Call via FTS Conferencing. Status: Open to the public. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the teleconference at the USA toll-free, dialin number, 1–866–659–0537 and the passcode is 9933701. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines, which have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction, which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the PO 00000 Frm 00051 Fmt 4703 Sfmt 9990 compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, rechartered on March 22, 2016 pursuant to Executive Order 13708, and will expire on September 30, 2017. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters for Discussion: The agenda for the conference call includes: Reporting Final SEC Petition Vote Count from November ABRWH Meeting for Area IV of Santa Susanna Field Laboratory (Ventura County, CA); Follow-up on Hooker Site Profile Review; Work Group and Subcommittee Reports; Status of SEC Petitions Update; Plans for the March 2017 Advisory Board Meeting; and Advisory Board Correspondence. The agenda is subject to change as priorities dictate. Contact Person for More Information: Theodore M. Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., Mailstop: E–20, Atlanta, GA 30329, Telephone (513)533–6800, Toll Free 1– 800–CDC–INFO, Email ocas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–30519 Filed 12–19–16; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\20DEN1.SGM 20DEN1

Agencies

[Federal Register Volume 81, Number 244 (Tuesday, December 20, 2016)]
[Notices]
[Page 92820]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-30523]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Office of Infectious Diseases 
(BSC, OID)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:
    Time and Date: 11:00 a.m.-1:00 p.m., EST, January 23, 2017.
    Place: Teleconference.
    Status: The meeting is open to the public; the toll free dial in 
number is 1-877-951-7311 with a pass code of 4530516.
    Purpose: The BSC, OID, provides advice and guidance to the 
Secretary, Department of Health and Human Services; the Director, CDC; 
the Director, OID; and the Directors of the National Center for 
Immunization and Respiratory Diseases, the National Center for Emerging 
and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, 
Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: 
Strategies, goals, and priorities for programs; research within the 
national centers; and overall strategic direction and focus of OID and 
the national centers.
    Matters for Discussion: Topics to be discussed during the 
teleconference include (1) discussion and vote on the Food Safety 
Modernization Act Surveillance Working Group Annual Report to the 
Secretary of Health and Human Services and (2) a report back from a 
recent external review of CDC's advanced molecular detection 
activities.
    The agenda and any supplemental material will be available at 
www.cdc.gov/oid/BSC/meetingschedule.html after January 16.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Robin Moseley, M.A.T., 
Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop 
D10, Atlanta, Georgia 30333, Telephone: (404) 639-4461.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2016-30523 Filed 12-19-16; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.